A farnesyltransferase inhibitor. Sensitizes human multiple myeloma cell to proteasome inhibition by blocking degradation of bortezomib(B675700)-induced aggresomes. Also shown to inhibit the growth of myeloid leukemia cell lines and primary leukemia cells
分子图谱
暂无数据
点击上传数据
参考文献
• Nagai, T., et al.: Leukemia Res., 34, 1057 (2010)
• Hong, D., et al.: Clin. Cancer Res., 15, 7061 (2009)